Evidence map›Paper›PMID 34446044›Full record

Observational studyWorld journal of surgical oncology2021

Risk scores to predict mortality 2 and 5 years after surgery for colorectal cancer in elderly patients.

Nerea González, Ane Loroño, Urko Aguirre, Santiago Lázaro, Marisa Baré, Maximino Redondo, Eduardo Briones, Cristina Sarasqueta, Amaia Bilbao, Nerea Fernández de Larrea and 2 more

Registry-linked trialOpen access · goldAbstract readObservational Study
In one paragraph

Observational study in World journal of surgical oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02488161 (Risk Factors of Adverse Outcomes at Short and Medium Term, and Development of Predictive Models, in Patients With Colorectal Cancer. IRYSS-coordinated Multicenter Study), which is not on this map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02488161 completednot on this map

Risk Factors of Adverse Outcomes at Short and Medium Term, and Development of Predictive Models, in Patients With Colorectal Cancer. IRYSS-coordinated Multicenter Study

TypeobservationalSponsorHospital Galdakao-UsansoloRan2010 to 2015Enrolled2,600ConditionsColorectal CancerArmsNo intervention
3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 11 institutions in 1 country.

Nerea GonzálezOsakidetza Basque Health Service, Galdakao - Usansolo Hospital (Research Unit), Galdakao, Basque Country, Spain. ngonzalez@kronikgune.org.ORCID http://orcid.org/0000-0003-3928-3274
Ane LoroñoOsakidetza Basque Health Service, Galdakao - Usansolo Hospital (Research Unit), Galdakao, Basque Country, Spain.
Urko AguirreOsakidetza Basque Health Service, Galdakao - Usansolo Hospital (Research Unit), Galdakao, Basque Country, Spain.
Santiago LázaroHealth Services Research on Chronic Patients Network, REDISSEC, Galdakao, Basque Country, Spain.
Marisa BaréHealth Services Research on Chronic Patients Network, REDISSEC, Galdakao, Basque Country, Spain.
Maximino RedondoHealth Services Research on Chronic Patients Network, REDISSEC, Galdakao, Basque Country, Spain.
Eduardo BrionesUDG Public Health, AP Sevilla district, Av. de Jerez, 41013, Sevilla, Spain.
Cristina SarasquetaHealth Services Research on Chronic Patients Network, REDISSEC, Galdakao, Basque Country, Spain.
Amaia BilbaoHealth Services Research on Chronic Patients Network, REDISSEC, Galdakao, Basque Country, Spain.
Nerea Fernández de LarreaEpidemiology National Centre, Institute of Health Carlos III, Calle de Melchor Fernández Almagro, 5, 28029, Madrid, Spain.
José María QuintanaOsakidetza Basque Health Service, Galdakao - Usansolo Hospital (Research Unit), Galdakao, Basque Country, Spain.
REDISSEC-CARESS/CCR group
Hospital Universitario La Paz · ESHospital de Galdakao · ESCentro de Investigación Biomédica en Red · ESHospital de Basurto · ESInstituto de Salud Carlos III · ESAndalusian Health Service · ESCentro de Investigación Biomédica en Red de Epidemiología y Salud Pública · ESOsasun Sistemen Ikerketa Institutua · ESBiogipuzkoa Health Research Institute · ESCorporació Sanitària Parc Taulí · ESUniversidad de Sevilla · ES

Funding

Instituto de Salud Carlos III PI09/90397Instituto de Salud Carlos III PI09/90441Instituto de Salud Carlos III PI09/90453Instituto de Salud Carlos III PI09/90460Instituto de Salud Carlos III PI09/90490Instituto de Salud Carlos III PI13/00013Instituto de Salud Carlos III PI13/01692Instituto de Salud Carlos III PS09/00314Instituto de Salud Carlos III PS09/00746Instituto de Salud Carlos III PS09/00805Instituto de Salud Carlos III PS09/00910KRONIKGUNE KRONIK 11/006Osasun Saila, Eusko Jaurlaritzako 2010111098
6 · The paper itself

Abstract

backgroundThe aim of this study was to identify predictors of mortality in elderly patients undergoing colorectal cancer surgery and to develop a risk score.

methodsThis was an observational prospective cohort study. Individuals over 80 years diagnosed with colorectal cancer and treated surgically were recruited in 18 hospitals in the Spanish National Health Service, between June 2010 and December 2012, and were followed up 1, 2, 3, and 5 years after surgery. Sociodemographic and clinical data were collected. The primary outcomes were mortality at 2 and between 2 and 5 years after the index admission.

resultsThe predictors of mortality 2 years after surgery were haemoglobin ≤ 10 g/dl and colon locations (HR 1.02; CI 0.51-2.02), ASA class of IV (HR 3.55; CI 1.91-6.58), residual tumour classification of R2 (HR 7.82; CI 3.11-19.62), TNM stage of III (HR 2.14; CI 1.23-3.72) or IV (HR 3.21; CI 1.47-7), LODDS of more than - 0.53 (HR 3.08; CI 1.62-5.86)) and complications during admission (HR 1.73; CI 1.07-2.80). Between 2 and 5 years of follow-up, the predictors were no tests performed within the first year of follow-up (HR 2.58; CI 1.21-5.46), any complication due to the treatment within the 2 years of follow-up (HR 2.47; CI 1.27-4.81), being between 85 and 89 and not having radiotherapy within the second year of follow-up (HR 1.60; CI 1.01-2.55), no colostomy closure within the 2 years of follow-up (HR 4.93; CI 1.48-16.41), medical complications (HR 1.61; CI 1.06-2.44), tumour recurrence within the 2 years of follow-up period (HR 3.19; CI 1.96-5.18), and readmissions at 1 or 2 years of follow-up after surgery (HR 1.44; CI 0.86-2.41).

conclusionWe have identified variables that, in our sample, predict mortality 2 and between 2 and 5 years after surgery for colorectal cancer older patients. We have also created risks scores, which could support the decision-making process.

trial registrationClinicalTrials.gov , NCT02488161 .

Indexed as

Colorectal NeoplasmsState MedicineAgedHumansNeoplasm Recurrence, LocalPrognosisProspective StudiesRisk FactorsColorectal cancerElderlyMortalityOutcomeRisk scoreSurgery

Identifiers

PMID34446044
PMCPMC8394051
OpenAlexW3194095064

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.